Studies
Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Aterostenosis (CAPTIVA)
Neurology
Heart and Vascular
Stroke
Vascular Disease
Adult Subjects
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
Validation of Early Prognostic Data for Recovery Outcome after Stroke for Future, Higher Yield Trials (VERIFY)
Neurology
Stroke
Healthy Subjects
Adult Subjects
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, transmagnetic stimulation (TMS), and MRI measures in the acute stroke time window.